Tietueen sitaatit

APA-viite (7. p.)
Ang, C. W., Laman, J. D., Willison, H. J., Wagner, E. R., Endtz, H. P., De Klerk, M. A., . . . Doorn, P. A. V. (2002). Structure of Campylobacter jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients. Infect Immun.
Chicago-viite (17. p.)
Ang, C. W., et al. "Structure of Campylobacter Jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients." Infect Immun 2002.
MLA-viite (9. p.)
Ang, C. W., et al. "Structure of Campylobacter Jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients." Infect Immun, 2002.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.